RecruitingNot ApplicableNCT07218718

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

A Pilot Study Examining the Feasibility of Oral Cryotherapy (Popsicles) in Decreasing Dysgeusia in Patients With Prostate Cancer Receiving Single Agent Taxane Therapy


Sponsor

City of Hope Medical Center

Enrollment

60 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial studies whether cooling the mouth with popsicles (oral cryotherapy) decreases taste changes in prostate cancer patients receiving taxane chemotherapy. Patients receiving chemotherapy can experience a variety of side effects. Changes in the taste of food is a frequent complaint of patients receiving chemotherapy and is underreported as patients may think that it is unavoidable and not manageable. Taxane-based chemotherapy is thought to be associated with the most taste changes of any chemotherapy. Taste buds contain a specific type of cell, called gustatory cells, that are located on the surface of the tongue, the soft palate (back, muscular part of the roof of the mouth), and the upper part of the esophagus. These cells consist of five basic tastes: salty, sweet, sour, bitter, and umami (or savory). Oral cryotherapy involves cooling the mouth with ice chips, popsicles, or other cold drinks for several minutes before, during, and after chemotherapy causing the tiny blood vessels in the protective linings inside the mouth to narrow. It is thought that this narrowing will reduce blood flow to the cooled areas, thereby decreasing the amount of chemotherapy that is delivered to the fragile protective linings inside the mouth that causes the taste changes. This may be an effective way to decrease taste changes in prostate cancer patients receiving taxane chemotherapy.


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether sucking on popsicles (oral cryotherapy — applying cold to the mouth) during chemotherapy infusions can prevent taste changes in men with prostate cancer receiving taxane chemotherapy. Taste changes are a common and distressing side effect of certain chemotherapy drugs. **You may be eligible if...** - You have prostate cancer - You are 18 or older and are about to start your first course of a taxane chemotherapy drug (such as docetaxel or cabazitaxel) - You have not received chemotherapy before - You are generally well enough for treatment (ECOG score of less than 2) - You are willing to suck on popsicles during your infusions and complete surveys - You speak English **You may NOT be eligible if...** - You already have taste problems before starting treatment - You have had previous oral surgery or have oral abnormalities - You are receiving the chemotherapy drug oxaliplatin (which causes cold sensitivity in the mouth) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBest Practice

Receive usual care

PROCEDUREOral Cryotherapy

Undergo oral cryotherapy

OTHERSurvey Administration

Ancillary studies


Locations(1)

City of Hope Medical Center

Duarte, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07218718


Related Trials